Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
01/15/2018 01/16/2018 01/17/2018 01/18/2018 01/19/2018 Date
172.5(c) 173.5(c) 173(c) 172.75(c) 174.925 Last
72 893 80 371 64 732 30 744 31 410 Volume
+1.17% +0.58% -0.29% -0.14% +1.26% Change
More quotes
Financials ($)
Sales 2017 1,58 M
EBIT 2017 -120 M
Net income 2017 -97,2 M
Finance 2017 23,9 M
Yield 2017 -
Sales 2018 2,98 M
EBIT 2018 -130 M
Net income 2018 -101 M
Finance 2018 95,5 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 345x
EV / Sales2018 159x
Capitalization 567 M
More Financials
Company
PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune.It operates through the following segments: Growth Stage Businesses; Project Phase Businesses; and... 
More about the company
Surperformance© ratings of Puretech Health PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on PURETECH HEALTH PLC
01/03 PURETECH HEALTH : Affiliate resTORbio Adds Lynne Sullivan, Biogen Senior Vice Pr..
01/03 PURETECH HEALTH : resTORbio Appoints Lynne Sullivan to Its Board of Directors
01/02 PURETECH HEALTH : Affiliate resTORbio Files Public Registration Statement for Pr..
2017 PURETECH HEALTH : Affiliate Entrega to Receive $5 Million for Eli Lilly Collabor..
2017 PURETECH HEALTH : Entrega To Receive $5 Million Investment from Lilly To Advance..
2017 ENTREGA : To Receive $5 Million Investment from Lilly To Advance Proprietary Ora..
2017 PURETECH HEALTH : Vedanta Biosciences Granted Four New US Patents Expanding Cove..
2017 VEDANTA BIOSCIENCES : Granted Four New U.S. Patents Expanding Coverage for Compo..
2017 PURETECH HEALTH : resTORbio Appoints Paul Fonteyne to Its Board of Directors
2017 PURETECH HEALTH : Affiliate resTORbio Adds Paul Fonteyne, CEO of Boehringer Inge..
More news
Sector news : Biotechnology & Medical Research - NEC
01/17 CELGENE : Conducts Deal Talks With Juno -- WSJ
01/16 CELGENE : in Talks to Buy Juno Therapeutics -- Update
01/16 CELGENE : in Talks to Buy Juno Therapeutics
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
01/14UConn to review planned speech by conservative pundit Ben Shapiro
55
01/14UConn’s College Republicans are planning to bring Ben Shapiro, editor-in-chie..
8
01/14Ben Shapiro event triggers UConn's new review process  
01/13WATCH: Ben Shapiro defends Trump "shithole" remark: "Some countries are reall..
42
01/12WATCH: Ben Shapiro defends Trump "shithole" remark: "Some countries are reall..
44
More tweets
Qtime:78
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 3,42 $
Spread / Average Target 43%
EPS Revisions
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Eric Elenko Chief-Research & Strategy
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC15.17%567
CELLTRION, INC.--.--%37 510
IQVIA HOLDINGS INC2.37%20 782
LONZA GROUP0.76%20 640
INCYTE CORPORATION-4.65%19 399
ALNYLAM PHARMACEUTICALS, INC.-1.42%12 192